Charles Warden is a distinguished entrepreneur and seasoned investor, currently serving as the Co-Founder and CEO of Aquea Health, Inc., and a Managing Director at Versant Ventures. With an MBA from Harvard Business School, Charles has honed his expertise in strategic planning, market assessment, operations, and business development across the healthcare and life sciences sectors.At Aquea Health, Charles leads a team dedicated to pioneering medical innovations, overseeing all facets of the business from R&D to clinical development and fundraising. His leadership extends to Versant Ventures, where he manages legacy funds, contributing to the firm's reputation in fostering medical advancements.Charles's investment acumen is evident from his track record of successful exits and IPOs, including notable companies like Ocular Therapeutix, Insulet, and Confluent Surgical, among others. His strategic involvement has been crucial in advancing technologies ranging from drug delivery systems and surgical tools to non-invasive treatments, significantly impacting patient care.His role as a board member in various companies underscores his ability to guide firms from inception through to successful exits, demonstrating a profound understanding of the dynamics in startup and growth phases. Charles's contributions to the healthcare industry are marked by a commitment to innovation and excellence, making him a key figure in transforming medical care through strategic investment and leadership.